Once daily glycopyrronium for the treatment of COPD: pooled analysis of the GLOW1 and GLOW2 studies

MLA

Pankaj Goyal, et al. Once Daily Glycopyrronium for the Treatment of COPD: Pooled Analysis of the GLOW1 and GLOW2 Studies. Jan. 2020. EBSCOhost, https://doi.org/10.6084/m9.figshare.11830212.v1.

APA

Pankaj Goyal, Hungta Chen, Peter D’Andrea, Anthony D’Urzo, Edward Kerwin, & Tim Overend. (2020). Once daily glycopyrronium for the treatment of COPD: pooled analysis of the GLOW1 and GLOW2 studies. https://doi.org/10.6084/m9.figshare.11830212.v1

Chicago

Pankaj Goyal, Hungta Chen, Peter D’Andrea, Anthony D’Urzo, Edward Kerwin, and Tim Overend. 2020. “Once Daily Glycopyrronium for the Treatment of COPD: Pooled Analysis of the GLOW1 and GLOW2 Studies,” January. doi:10.6084/m9.figshare.11830212.v1.